Insulin Resistance as a Proinflammatory State: Mechanisms, Mediators, and Therapeutic Interventions

Author(s): Rajesh Garg, Devjit Tripathy, Paresh Dandona

Journal Name: Current Drug Targets

Volume 4 , Issue 6 , 2003

Become EABM
Become Reviewer
Call for Editor


Insulin resistance has been recognized as an inflammatory disease based on the scientific evidence collected over the last decade. Inflammatory markers like CRP, PAI-1, IL-6 are present in higher concentrations in insulin resistant people than in normal people. Mechanisms, linking inflammation to insulin resistance are being explored and progress has been made in this direction. TNFα has been shown to be responsible for insulin resistance in obese subjects. Macronutrient intake may also induce inflammation whereas fasting has antiinflammatory effects. Insulin itself has been found to be anti-inflammatory and this action may be useful in many disease states. Thiazolidinediones, such as rosiglitazone that act primarily as insulin sensitisers, have a profound anti-inflammatory and potentially antiatherosclerotic activity. These effects may be of considerable clinical significance if sustained during long-term therapy, given the morbidity and mortality associated with atherosclerosis, the major complication of insulin resistance.

Keywords: insulin resistance, inflammation, cytokines, insulin, anti-inflammatory activity

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2003
Page: [487 - 492]
Pages: 6
DOI: 10.2174/1389450033490920
Price: $65

Article Metrics

PDF: 5